palladium has been researched along with daunorubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiallo, MM; Garnier-Suillerot, A | 1 |
| Czaplewska, JA; Görls, H; Gottschaldt, M; Koth, D; Obata, M; Onambele, LA; Prokop, A; Schubert, US; Yano, S | 1 |
2 other study(ies) available for palladium and daunorubicin
| Article | Year |
|---|---|
Metal anthracycline complexes as a new class of anthracycline derivatives. Pd(II)-adriamycin and Pd(II)-daunorubicin complexes: physicochemical characteristics and antitumor activity.
Topics: Animals; Cardiolipins; Cell Division; Circular Dichroism; Daunorubicin; Doxorubicin; Hydrogen-Ion Concentration; Kinetics; Leukemia P388; Leukemia, Experimental; Liposomes; Male; Mice; Mice, Inbred Strains; NADH Dehydrogenase; Palladium; Phosphatidylcholines; Spectrometry, Fluorescence; Spectrophotometry; Structure-Activity Relationship | 1986 |
Mitochondrial mode of action of a thymidine-based cisplatin analogue breaks resistance in cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Crystallography, X-Ray; Cytarabine; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fas-Associated Death Domain Protein; Genes, bcl-2; Humans; Magnetic Resonance Spectroscopy; Mitochondria; Molecular Structure; Organoplatinum Compounds; Palladium; Thymidine; Vincristine | 2010 |